Rep. Price Faces Growing Scrutiny Over Health Care Stocks
Rep. Louise Slaughter, D-N.Y., has asked the Securities and Exchange Commission to investigate.
The Associated Press:
Trump's HHS Pick Faces Calls For Probe Of Stock Trades
President-elect Donald Trump's nominee to be the nation's top health official is facing calls for investigation of whether his stock picks were guided by insider knowledge gleaned as a senior member of Congress. Rep. Tom Price, R-Ga., was chosen by Trump in part because of his plan to repeal "Obamacare," and his confirmation hearings are expected to be a spirited debate about the future of federal health insurance programs. Financial issues could take the hearings in a different direction, however, to determine whether there were any potential violations of federal law. (Alonso-Zaldivar, 1/11)
The Wall Street Journal:
Lawmaker Asks SEC To Investigate Stock Trades Of HHS Nominee Tom Price
A veteran legislator who wrote a law to curtail abusive stock-trading in Congress on Tuesday asked securities regulators to open an investigation into President-elect Donald Trump’s nominee to be secretary of Health and Human Services. The request to investigate Rep. Tom Price, a Georgia Republican, comes after The Wall Street Journal reported last month that he made trades worth more than $300,000 in stocks of biomedical, pharmaceutical and health insurers while serving on the health subcommittee of the House Ways and Means Committee, sponsoring and advocating legislation that potentially could affect those companies’ stock. (Grimaldi, 1/10)
See past KHN coverage on the nominee for HHS secretary: Trump’s Health Secretary Nominee Sought Special Treatment for Industry Donors
